发明名称 SURFACE TREATMENT OF SARS-INFECTED LUNGS
摘要 SARS infection has wreaks havoc in China, Hong Kong and Taiwan and its effects sending repercussion throughout the entire international society. The death rate has been high and the Chinese and western medical social were quite helpless about hits. For more than hundreds of years, lung infectious diseases have always been classified under medical science as internal organs disease. However, today, this paper will point out that this opinion has been misunderstood. There is a need to associate such infection disease with air as an interface. Therefore, SARS infection is a kind surface ulcerous infection. Since there have been changes from the above-mentioned medical science opinion, we have found the best medical scheme. It will no longer be a dream for SARS infected patients to be discharge from the hospital in a matter of hours. The SARS infected will no longer be life threatening again. Hence, mankind can proudly declare their triumph over SARS. "Surface Treatment infected of SARS infected lungs" is under the brand new medical concept of the outcome. The "01 Therapy" is the core of the "Surface Treatment". The sterilizing liquid that is infected into the lung lobes is the surface treatment liquid for 01 therapy of the lungs. The formal name for this liquid is Per Fluoro Chemical (PFC) and the sterilizing is ozone.
申请公布号 WO03094902(A3) 申请公布日期 2004.05.27
申请号 WO2003SG00145 申请日期 2003.06.12
申请人 LIN, ZHEM-MAN 发明人 LIN, ZHEM-MAN
分类号 A61K31/02;A61K31/755;A61K33/00;A61K33/40;A61L2/00;A61P31/14 主分类号 A61K31/02
代理机构 代理人
主权项
地址
您可能感兴趣的专利